JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease

847Citations
Citations of this article
629Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The discovery of the Janus kinase (JAK)-signal transducer and activator of transcripton (STAT) signaling pathway, a landmark in cell biology, provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins. As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technology that permits genome-wide views. As we celebrate the 20 th anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease. Not only have genome-wide association studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease. © 2012 Elsevier Inc..

Cite

CITATION STYLE

APA

O’Shea, J. J., & Plenge, R. (2012, April 20). JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease. Immunity. https://doi.org/10.1016/j.immuni.2012.03.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free